NCT03870126 is a NA clinical trial of Flavored beverage in Mental Energy, sponsored by PepsiCo Global R&D.

Who is sponsoring NCT03870126?

NCT03870126 is sponsored by PepsiCo Global R&D.

What drugs are being tested in NCT03870126?

Interventions in NCT03870126: Flavored beverage.

What condition does NCT03870126 study?

NCT03870126 studies Mental Energy, Physical Performance.

Is NCT03870126 still recruiting?

NCT03870126 is currently completed. Last updated 18 January 2020.

Last reviewed 2020-01-18 · How we verify

NCT03870126

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Dose Effect of a Plant Extract on Fatigue

Completed NA Last updated 18 January 2020

What this trial tests

NA trial testing Flavored beverage in Mental Energy in 28 participants. Completed in 6 December 2019.

Timeline

29 January 2019

Primary endpoint
6 December 2019

6 December 2019

Quick facts

Lead sponsor	PepsiCo Global R&D
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	quadruple
Primary purpose	basic science
Enrollment	28
Start date	29 January 2019
Primary completion	6 December 2019
Estimated completion	6 December 2019
Sites	1 location across United States

Drugs / interventions tested

Flavored beverage

Conditions studied

Mental Energy — all drugs for Mental Energy →
Physical Performance — all drugs for Physical Performance →

Sponsor

PepsiCo Global R&D — full company profile →

Who can join

Adults 18 to 49, any sex, with Mental Energy or Physical Performance. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Test the short-term effects of the acute consumption of two separate beverages containing different concentrations of polyphenols, a beverage containing 75 mg of caffeine and a flavored placebo beverage on mental energy and physical performance

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Modulatory Effects of Phytochemicals on Gut-Brain Axis: Therapeutic Implication.
Jaberi KR, Alamdari-Palangi V, Savardashtaki A, Vatankhah P, et al · · 2024 · cited 21× · PMID 38939650 · DOI 10.1016/j.cdnut.2024.103785

Verify or expand the search:

Other PepsiCo Global R&D trials

Trials by the same sponsor.

NCT07429201 — Comparing an Electrolyte-Carbohydrate Beverage to Water During Ramadan · NA · completed
NCT07400614 — Evaluating the Impact of Energy Drink Formulas on Alertness for an Extended Period · NA · recruiting
NCT07427654 — Determination of the Glycemic Index of Products Varying in Levels of Refined and Whole Grain Corn · NA · completed
NCT07298863 — The Effect of Hydration Status on Substrate Oxidation at Rest and During Light and Moderate Exercise · NA · recruiting
NCT07217834 — Effects of a Glycerol-Electrolyte Beverage on Fluid Balance in Healthy Euhydrated Men and Women · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03870126 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by PepsiCo Global R&D
Last refreshed: 18 January 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03870126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing